Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs.
about
Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic PericarditisImpairment of aspirin antiplatelet effects by non-opioid analgesic medicationNon-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic reviewCommon Analgesic Agents and Their Roles in Analgesic Nephropathy: A Commentary on the EvidenceRegular use of analgesics is a risk factor for renal cell carcinomaDrugs for pain management in dentistryAnalgesics use and ESRD in younger age: a case-control studyNonsteroidal Anti-Inflammatory Drugs and the KidneyRole of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics.End stage renal disease.Age-related associations of hypertension and diabetes mellitus with chronic kidney disease.Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer riskThe renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly.Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies.Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice.End-stage renal diseaseRisk factors for chronic kidney disease: an updatePredicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study.Use and abuse of over-the-counter analgesic agents.Acetaminophen (Tylenol): Johnson & Johnson and consumer safety.Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.The status of ongoing trials for mild cognitive impairment.Herbal medicines for the treatment of osteoarthritis: a systematic review.Drug-associated renal dysfunction and injury.Pathophysiology and first-line treatment of osteoarthritis.Patterns and predictors of non-prescription medicine use among Malaysian pharmacy patrons: a national cross sectional study.A double-blind, randomized, multicentric, placebo-controlled clinical trial of antarth, a phytomedicine, in the treatment of osteoarthritisA safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine.Chronic non-cancer pain in older people: current evidence for prescribing.Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States.Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis.Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs.Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan.Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics.Measuring quality in arthritis care: the Arthritis Foundation's Quality Indicator set for osteoarthritis.Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.Chemical-induced nephropathy: a review of the renal tubulointerstitial lesions in humans.Oral and dental aspects of chronic renal failure.
P2860
Q26749687-8134F2E5-1D8E-4254-AFFC-D494A08603B5Q26801633-A5579F4C-ED71-4D2C-9EEC-F2C51F3016E0Q27000437-9E93C134-075C-4A23-926D-38D6CF9873A8Q28069834-77C16F78-579D-42F2-A846-0F9CE258BA70Q28162607-05B5DE2C-0847-4F5C-9457-CD64F261E633Q28194546-CAE2E606-F8E1-41AC-973A-A27710888BBCQ28383308-99F7F079-D0BD-4D05-8662-8397DDDFDE28Q28386844-698876BD-72E4-4BB9-B61D-74355CE2123AQ31722850-733E7612-17A9-4817-8804-570C221E4158Q33446829-CE7C768D-3EEE-4958-AA40-AEBEA50B8700Q33475999-321C1A68-8CA2-4453-8EDB-5EFC4361163AQ33579128-E46C329F-91AB-4ED6-A623-438A6F9DC0BBQ33627839-D2C0077C-4634-4299-8BBF-FD266894BB32Q33633390-800A9186-8306-48AF-933B-ABCD71C8654BQ33774754-26C19F69-7658-4898-816D-572867E65CC8Q33815886-BD6FF95F-4FAB-4164-B936-7629CCF2FAE1Q33850437-01BA3804-47AA-4AA5-9499-E632FCCB61D3Q33873248-2D36E23D-7FCC-42AA-8FDE-60EB7384A4F1Q33890631-1501008B-452C-496C-A421-B2FCB867D8A8Q33922000-3B42BE7C-FFB4-4D5E-BB33-6F22992FEA6EQ34077611-933D88F2-8456-4594-B95D-48D6CDE714EFQ34109959-79B3AE5E-9E7C-4F79-A969-BAE2980AB886Q34204390-4A1604E0-E18A-4146-8A30-3DCBA6AE8455Q34321825-76684D09-8C6D-441D-80C2-0714936501C6Q34560483-5816D554-0F6A-4146-AD7C-5A1AF6D3C604Q34579637-AF7D80F7-916B-4E04-BA96-14815E57FC33Q34661665-84A13B95-050C-450F-BACC-2CDD483AAEEAQ34706507-A1823482-C08B-4E0F-8B87-119C830C6E43Q34755385-96AD1781-1105-44AA-ACCA-F5374666CBABQ34793903-2E7F44C6-3E46-4703-8FEA-5356E9B204C5Q35259610-173B2281-50B0-4472-A8AF-03BE3E9F7430Q35448046-7D543CAE-BE3D-492E-BE72-F6C19469C971Q35548804-B3C86406-8FB1-419C-A155-06C2EDE81A12Q35615269-31823EF3-76CB-4D68-89DD-7666607CBA9DQ35792346-3DBBA10D-7548-4AB7-856E-6ACD8D04288FQ35799572-84BAAC9D-1CBB-450A-9FF3-A5309BA77122Q35873392-80F9C8F9-957B-499D-84BA-E5687A63A739Q35903367-C6A1D052-193E-4D24-9D00-236D85E59F50Q35927205-C617EDE6-46C7-4DE6-9174-68CBA986AB95Q36050817-A1F8158B-EA7F-4F5B-B070-0232A663B5E6
P2860
Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@ast
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@en
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@nl
type
label
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@ast
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@en
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@nl
prefLabel
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@ast
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@en
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@nl
P2093
P1476
Risk of kidney failure associa ...... roidal antiinflammatory drugs.
@en
P2093
P304
P356
10.1056/NEJM199412223312502
P407
P577
1994-12-01T00:00:00Z